Literature DB >> 12172300

Systolic and diastolic blood pressure control in antihypertensive drug trials.

Giuseppe Mancia, Guido Grassi.   

Abstract

Mesh:

Substances:

Year:  2002        PMID: 12172300     DOI: 10.1097/00004872-200208000-00001

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  46 in total

Review 1.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

2.  Treating hypertension with guidelines in general practice.

Authors:  Neil C Campbell; Peter Murchie
Journal:  BMJ       Date:  2004-09-04

3.  Cardiovascular risk stratification and antihypertensive therapy according to guidelines in the outpatient setting.

Authors:  Jörg Slany; Günther Nirnberger; Lothar A Pittrow
Journal:  Wien Med Wochenschr       Date:  2011-09-30

4.  Efficacy and safety of treatment of hypertensive patients with fixed combination perindopril/indapamide up to 10/2.5 mg: results of the FALCO FORTE programme.

Authors:  Daniel Pella
Journal:  High Blood Press Cardiovasc Prev       Date:  2011-09-01

5.  JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Authors: 
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 6.  Vascular calcium channels and high blood pressure: pathophysiology and therapeutic implications.

Authors:  Swapnil Sonkusare; Philip T Palade; James D Marsh; Sabine Telemaque; Aleksandra Pesic; Nancy J Rusch
Journal:  Vascul Pharmacol       Date:  2006-01-20       Impact factor: 5.773

7.  Organisational factors in relation to control of blood pressure: an observational study.

Authors:  Melanie Inkster; Alan Montgomery; Peter Donnan; Tom MacDonald; Frank Sullivan; Tom Fahey
Journal:  Br J Gen Pract       Date:  2005-12       Impact factor: 5.386

Review 8.  Lessons from trials in hypertensive type 2 diabetic patients.

Authors:  Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 9.  Antihypertensive treatment and stroke prevention: from recent meta-analyses to the PRoFESS trial.

Authors:  Guido Grassi; Fosca Quarti-Trevano; Raffaella Dell'oro; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2009-08       Impact factor: 5.369

Review 10.  Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention.

Authors:  David J Hyman; Valory N Pavlik
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.